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Abstract: We report on our efforts to create efficient
artificial metalloenzymes for the enantioselective hy-
drogenation of N-protected dehydroamino acids
using either avidin or streptavidin as host proteins.
Introduction of chiral amino acid spacers – phenyl-
alanine or proline – between the biotin anchor and
the flexible aminodiphosphine moiety 1, combined
with saturation mutagenesis at position S112X of
streptavidin, affords second generation artificial hy-
drogenases displaying improved organic solvent tol-
erance, reaction rates (3-fold) and (S)-selectivities
(up to 95% ee for N-acetamidoalanine and N-acet-
amidophenylalanine). It is shown that these artificial
metalloenzymes follow Michaelis–Menten kinetics
with an increased affinity for the substrate and a
higher kcat than the protein-free catalyst (compare
kcat 3.06 min
1 and KM 7.38 mM for [Rh ACHTUNGTRENNUNG(COD)Biot-
1]+ with kcat 12.30 min
1 and KM 4.36 mM for [Rh-
ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+  WT Sav). Finally, we
present a straightforward protocol using Biotin-Se-
pharose to immobilize artificial metalloenzymes
(>92% ee for N-acetamidoalanine and N-acetami-
dophenylalanine using [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+ 
Sav S112W).
Keywords: artificial metalloenzymes; biotin-avidin;
chemogenetic optimization; enantioselective cataly-
sis; enzyme immobilization; hydrogenation
Introduction
Today, the preparation of enantiomerically pure com-
pounds is one of the most actively pursued fields in
synthetic chemistry. In this major effort, both homo-
geneous and enzymatic catalysis occupy a place of
choice.[1–3] To complement these well established
methods, organocatalysis and artificial metalloen-
zymes have witnessed a revival in recent years.[4]
The underlying principle of artificial metalloen-
zymes for enantioselective catalysis is based on the in-
corporation of an active catalyst within a macromo-
lecular host (protein or oligonucleotide) which pro-
vides a chiral environment, responsible for the selec-
tivity.[5–10] To ensure localization of the catalytic
moiety within the macromolecular host, covalent,
dative and supramolecular anchoring strategies have
successfully been exploited to produce enantioselec-
tive hybrid catalysts for ester hydrolysis,[11] dihydroxy-
lation,[12] epoxidation,[13,14] sulfoxidation,[15–19] hydroge-
nation,[20–28] transfer hydrogenation[29,30] and Diels–
Alder reactions.[31–33]
Based on WhitesidesG early report,[20] several groups
have been exploiting the biotin-avidin technology to
produce artificial hydrogenases for the enantioselec-
tive reduction of N-protected dehydroamino
acids[21–26,28] as well as the reduction via transfer hy-
drogenation of aromatic ketones.[29,30]
For optimization purposes, our group relies both on
chemical and on genetic strategies (i.e., chemogenet-
ic)[5] to yield both (R)- and (S)-selective hydrogenases.
For the proof-of-principle, we focused exclusively on
achiral ligand scaffolds and spacers, thus ensuring that
(enantio)selectivity is provided by second coordina-
tion sphere interactions between the catalyst–sub-
strate moiety and the host protein. Having produced,
purified and screened several streptavidin (Sav here-
after) mutants, we identified position S112 as a prom-
ising mutation site to perform saturation mutagene-
sis.[23] Combining the twenty Sav S112X with eighteen
achiral biotinylated diphosphine ligands afforded ver-
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satile artificial hydrogenases displaying moderate to
good enantioselectivities for both enantiomers of N-
protected amino acids (N-acetamidoalanine, N-
AcAla, and N-acetamidophenylalanine, N-AcPhe).[34]
Herein we report on our efforts to produce more
active and selective artificial hydrogenases based on
the biotin-avidin technology, with an emphasis on the
use of enantiopure a-amino acid spacers (Scheme 1).
We show that this second generation of hybrid cata-
lysts displays increased stability towards organic sol-
vents, increased selectivity and increased reaction
rates. In addition, we show that, by exploiting the tet-
rameric nature of (strept)avidin [hereafter, (strept)-
avidin refers to either avidin or streptavidin], such ar-
tificial metalloenzymes can be immobilized using
commercially available Biotin-Sepharose with little
erosion of their performance. A preliminary account
of this work has appeared recently.[26]
Results and Discussion
Chemogenetic Diversity
In previous studies, we showed that the ligand scaf-
fold plays a critical role on the performance of the re-
sulting artificial hydrogenases [Rh ACHTUNGTRENNUNG(COD)(Biot-
spacer-diphosphine)]+  (strept)avidin. For this study,
we used exclusively the most versatile ligand scaffold
1 and focused on the influence of the amino acid
spacer (Scheme 2).
In order to exploit more efficiently the interactions
between the spacer and the (strept)avidin host pro-
tein, phenylalanine and proline spacers were selected.
Scheme 1. Second generation artificial metalloenzymes
based on the biotin-avidin technology for the reduction of
N-acetamidodehydroamino acids. The host protein [(strept)-
avidin] displays high affinity for the anchor (biotin); intro-
duction of an enantiopure a-amino acid spacer, combined
with a flexible diphosphine ligand allows us to chemically
optimize both the activity and the selectivity. Site-directed
mutagenesis further enables a genetic optimization of the
host protein to afford enantioselective artificial hydrogenas-
es.
Scheme 2. Biotinylated ligands used in this study and standard operating conditions for the hydrogenation of a cocktail mix-
ture containing a-acetamidoacrylic acid and a-acetamidocinnamic acid (50 equivalents of each with respect to the biotinylat-
ed ligand).
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We speculated that the phenylalanine spacer might
display stabilizing p–p interactions upon interaction
with the hydrophobic (strept)avidin binding pockets,
which possess four or five aromatic residues for strep-
tavidin and avidin, respectively. We reasoned that a
proline moiety would restrict the degrees of freedom
of the biotinylated ligand, thus contributing to local-
ize the catalytic moiety within a well defined position
in (strept)avidin.
Both enantiomers of the Boc-protected amino acid
spacers were coupled to the aminodiphosphine
moiety 1. Following deprotection, (+)-biotin was in-
troduced to afford Biot-(R)-Pro-1, Biot-(S)-Pro-1,
Biot-(R)-Phe-1, Biot-(S)-Phe-1. This N!C coupling
scheme avoids epimerization – via formation of an in-
termediate oxazolone – upon the second peptide cou-
pling step. Full experimental details for the ligands
synthesis and spectroscopic characterization can be
found in the preliminary account of this work.[26]
These ligands were reacted in situ with [Rh-
ACHTUNGTRENNUNG(COD)2]BF4 and combined either with WT avidin or
with the twenty isoforms of streptavidin obtained by
saturation mutagenesis at position S112X. The result-
ing artificial hydrogenases [Rh ACHTUNGTRENNUNG(COD)(Biot-spacer-
1)]+  (strept)avidin were screened with a cocktail
mixture containing a-acetamidoacrylic acid and a-
acetamidocinnamic acid (fifty equivalents of each
with respect to the biotinylated ligand), Scheme 2.
Control experiments demonstrated that both the se-
lectivity and the conversion obtained with the cocktail
mixture are identical to those obtained with a single
substrate (i.e., no autoinduction).[35,36]
The results of the chemogenetic optimization are
summarized in Scheme 3 using a fingerprint display
for each substrate-protein-ligand combination.[25,37]
The selectivity is colour-coded [green for (R)-selectiv-
ity and pink for (S)-selectivity] and the intensity of
the colour codes for the conversion. Both substrates
are displayed as two hypothenuse-sharing triangles to
allow a rapid identification of interesting ligand-pro-
tein combinations. Selected results are collected in
Table 1, and a summary of all catalytic experiments is
provided in the Supporting Information.
Inspection of the fingerprint (Scheme 3), reveals
several interesting trends.
i) The absolute configuration of the amino acid
spacer by-and-large determines the absolute configu-
ration of the reduction product. Both Biot-(R)-Pro-1
and Biot-(S)-Phe-1 favour (S)-reduction products,
while Biot-(S)-Pro-1 and Biot-(R)-Phe-1 produce
preferentially (R)-reduction products.
Combining Biot-(R)-Pro-1 with Sav mutants bear-
ing aromatic residues at position S112X affords the
most (S)-selective artificial hydrogenases (up to 95%
ee for both substrates, Table 1, entries 3 and 4). It
should be emphasized that, in the absence of (strep-
t)avidin, the biotinylated catalysts derived from the
enantiopure ligands afford nearly racemic products
(<10% ee in all cases).
ii) Depending on the amino acid residue at position
S112X, the hybrid catalysts derived from Biot-(S)-
Phe-1 can afford both (R)- and (S)-reduction prod-
ucts. For example, [Rh ACHTUNGTRENNUNG(COD)Biot-(S)-Phe-1]+  Sav
S112M and [Rh ACHTUNGTRENNUNG(COD)Biot-(S)-Phe-1]+  Sav S112H
Scheme 3. Fingerprint display of the results of the chemogenetic optimization for the reduction of a-acetamidoacrylic acid
(top triangle) and a-acetamidocinnamic acid (bottom triangle).
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yield quantitatively N-AcAla in 73% ee (R) and 87%
ee (S), respectively (Table 1, entries 10 and 11). For a
single mutation, this represents a difference in transi-
tion state free energy dDG>2.6 kcalmol1 at room
temperature. Irrespective of the absolute configura-
tion of the phenylalanine spacer, hybrid catalysts de-
rived from S112F, S112L, S112M, S112W and S112Y
streptavidin mutants afford preferentially the same
enantiomer. For example, both [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-
Phe-1]+  Sav S112M and [Rh ACHTUNGTRENNUNG(COD)Biot-(S)-Phe-
1]+  Sav S112M yield quantitatively (R)-N-AcAla in
86% ee and 73% ee, respectively (Table 1, entries 7
and 11). We speculate that the presence of a bulky
residue at position S112 outrules the preference im-
posed by the enantiopure Phe-spacer. This may be
achieved either by inverting the preferred enantioen-
riched ligand conformation or by forcing the prochiral
substrate to present its si-face to the biotinylated cata-
lyst.
iii) Both substrates afford comparable enantioselec-
tivities. However, slightly better conversions are gen-
erally obtained for the smaller product N-AcAla. Sig-
nificant substrate discrimination is found for catalysts
derived from Biot-(R)-Pro-1. For example, [Rh-
ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+  Sav S112K affords quanti-
tatively (S)-N-AcAla (88% ee), while the conversion
for the larger (S)-N-AcPhe remains modest (36%
conversion, 84% ee, Table 1, entry 2)
iv) Combining Biot-(R)-Pro-1 with WT Avi affords,
for the first time, good levels of enantioselection
(89% ee for N-AcPhe quantitative, Table 1 entry 1).
This may be of interest for future developments as
WT Avi is significantly cheaper that WT Sav.
In summary and in comparison to our previous
studies relying on achiral spacers,[22–25,34] the introduc-
tion of enantiopure spacers yields higher (S)-selective
artificial metalloenzymes. In addition, the genetic op-
timization by saturation mutagenesis at position
S112X Sav generates more diversity than previously
observed with achiral spacers.
Organic Solvent Tolerance and Catalyst
Immobilization
One of the main limitations of enantioselective cataly-
sis performed in aqueous media is the very limited
solubility of many substrates. The organic solvent tol-
erance should thus contribute to broaden the sub-
strate scope of these artificial metalloenzymes.
Having identified both (R)- and (S)-selective artifi-
cial hydrogenases (ee >90%), we proceeded to test
these hydrogenases in the presence of large amounts
of organic co-solvents. For this purpose, dimethyl sulf-
oxide (DMSO, miscible with water) and ethyl acetate
(EtOAc, non-miscible with water) were selected. The
results for the screening in the presence of the most
selective catalyst  protein combinations are summar-
ized in Table 2.
As can be appreciated from these data, the catalyst
derived from Biot-1 does not tolerate large amounts
of either DMSO or EtOAc (Table 2, entries 1 and
2).[26] Introduction of an enantiopure spacer confers
significant organic-solvent tolerance in the presence
of streptavidin and its mutants. Both (S)- and (R)-se-
lective catalysts [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+  Sav
S112W and [Rh ACHTUNGTRENNUNG(COD)Biot-(S)-Phe-1]+  Sav S112M
perform well in the presence of either 45% DMSO or
EtOAc (maximal ee erosion 12%, Table 2, entries 12
and 13, 15 and 16). In contrast to streptavidin iso-
forms as host proteins, avidin-based artificial metal-
loenzymes perform poorly in the presence 45%
DMSO (Table 2, compare entries 4/5 and 8/9). In the
presence of either 27% DMSO or EtOAc, the ero-
sion observed with [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+ 
WT-Avi is minimal (Table 2, entries 8 and 10).
Table 1. Numerical summary of selected results of the catalytic experiments.
Entry Ligand Protein ee[a] of
N-AcPhe
Conversion of
N-AcPhe
ee[a] of
N-AcAla
Conversion of
N-AcAla
1 Biot-(R)-Pro-1 WTAvi 89 quant.[b] 87 quant.[b]
2 Biot-(R)-Pro-1 S112K 84 36 88 quant.[b]
3 Biot-(R)-Pro-1 S112W 95 quant.[b] 95 quant.[b]
4 Biot-(R)-Pro-1 S112Y 93 97 92 quant.[b]
5 Biot-(R)-Phe-1 S112I 74 80 84 quant.[b]
6 Biot-(R)-Phe-1 S112L 74 88 83 quant.[b]
7 Biot-(R)-Phe-1 S112M 75 94 86 quant.[b]
8 Biot-(R)-Phe-1 S112Q 76 82 81 quant.[b]
9 Biot-(R)-Phe-1 S112R 82 75 84 quant.[b]
10 Biot-(S)-Phe-1 S112H -78 65 -87 quant.[b]
11 Biot-(S)-Phe-1 S112M 87 quant.[b] 73 quant.[b]
[a] ee in%, positive ee values in favour of the (R)-enantiomer, negative ee values in favour of the (S)-enantiomer.
[b] Quantitative; all listed experiments were performed at least in duplicate (see Supporting Information); N-AcPhe=N-
acetamidophenylalanine, N-AcAa=N-acetamidoalanine.
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In the past, we have shown that an artificial metal-
loenzymeGs selectivity is little affected upon varying
the ratio of [Rh ACHTUNGTRENNUNG(COD)Biot-1]+ versus WT Sav be-
tween one and four, suggesting that the occupancy of
one binding site does not significantly affect neigh-
bouring sites.[24] As streptavidin is a homo-tetrameric
protein, we thus speculated that it may be possible to
exploit one binding site to immobilize the artificial
metalloenzyme, leaving three sites for the incorpora-
tion of a biotinylated catalyst.
For this purpose, one equivalent of commercially
available Biotin-Sepharose was added to tetrameric
(strept)avidin prior to the addition of an excess bio-
tinylated catalyst precursor. After decanting the im-
mobilized catalyst precursors, thus removing the
excess biotinylated rhodium present in solution, these
were tested using the standard reaction conditions.
Selected results are collected in Table 2. As can be
appreciated, the immobilized artificial metalloen-
zymes are most often nearly as selective as their ho-
mogeneous counterparts. However, the activity de-
creases, especially for the larger a-acetamidocinnamic
acid substrate. The most versatile immobilized hybrid
catalyst is [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+  Sav S112W
which is as active and as selective as its homogeneous
counterpart (compare Table 1 entry 3 and Table 2
entry 14).
In the context of artificial metalloenzymes, recover-
ing the precious protein via a simple filtration step
offers a straightforward work-up procedure. In addi-
tion, a second catalytic run performed with this recy-
cled immobilized artificial metalloenzyme afforded
similar conversions and enantioselectivity compared
to the first catalytic run. For [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-
1]+  Sav S112W) with a-acetamidocinnamic acid, ee
94% (S), conversion 81%, compare with Table 2
entry 14. The third catalytic run however afforded a
significantly lower yield and enantioselectivity (ee
<30%, conversion <25%).
Michaelis–Menten Kinetics
Having identified efficient artificial metalloenzymes,
we proceeded to determine the Michaelis–Menten pa-
rameters for four catalytic systems: [Rh ACHTUNGTRENNUNG(COD)Biot-
1]+, [Rh ACHTUNGTRENNUNG(COD)Biot-1]+  WT Sav, [Rh ACHTUNGTRENNUNG(COD)Biot-
(R)-Pro-1]+  WT Sav and [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-
1]+  WT-Avi. In order to test the influence of the or-
ganic co-solvent, catalysis with the latter two hybrid
catalysts was performed in 30% DMSO, thus ensuring
good levels of selectivity both for streptavidin and for
avidin based systems (compare entries 4/5 and en-
tries 8/9, respectively, in Table 2). For convenience,
the reactions were carried out at 2 bar hydrogen pres-
sure and room temperature. For solubility reasons,
only the more soluble substrate N-acetamidoacrylic
Table 2. Numerical summary of selected results of the catalytic experiments performed in the presence of organic solvents or
with immobilized artificial metalloenzymes.
Entry Ligand Protein Organic solvent ee[a] of
N-AcPhe
Conversion of
N-AcPhe
ee[a] of
N-AcAla
Conversion of
N-AcAla
1[b] Biot-1 WT Sav 45% DMSO 24 9 16 71
2[b] Biot-1 WT Sav EtOAc 31 5 30 56
3 Biot-1 WT Sav Immob.[d] 93 78 83 quant.[c]
4 Biot-(R)-Pro-1 WT Sav 27% DMSO 91 100 87 quant.[c]
5[b] Biot-(R)-Pro-1 WT Sav 45% DMSO 86 94 87 quant.[c]
6[b] Biot-(R)-Pro-1 WT Sav EtOAc 87 85 83 90
7 Biot-(R)-Pro-1 WT Sav Immob.[d] 89 36 76 76
8 Biot-(R)-Pro-1 WTAvi 27% DMSO 82 94 86 quant.[c]
9 Biot-(R)-Pro-1 WTAvi 45% DMSO 15 34 37 quant.[c]
10 Biot-(R)-Pro-1 WTAvi EtOAc 89 77 87 quant.[c]
11 Biot-(R)-Pro-1 WTAvi Immob.[d] 80 32 76 quant.[c]
12 Biot-(R)-Pro-1 S112W 45% DMSO 88 56 85 quant.[c]
13 Biot-(R)-Pro-1 S112W EtOAc 94 86 94 quant.[c]
14 Biot-(R)-Pro-1 S112W Immob.[d] 94 89 92 quant.[c]
15 Biot-(S)-Phe-1 S112M 45% DMSO 75 68 69 quant.[c]
16 Biot-(S)-Phe-1 S112M EtOAc 81 78 64 quant.[c]
17 Biot-(S)-Phe-1 S112M Immob.[d] 81 50 33 quant.[c]
[a] ee in%, positive ee values in favour of the (R)-enantiomer, negative ee values in favour of the (S)-enantiomer.
[b] Data from ref.[26]
[c] Quantitative.
[d] Immobilized using Biotin-Sepharose; all listed experiments were performed at least in duplicate (See Supporting Infor-
mation); N-AcPhe=N-acetamidophenylalanine, N-AcAla=N-acetamidoalanine.
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acid was used. The results are displayed in Figure 1
and summarized in Table 3.
These data reveal several noteworthy features:
i) All catalytic systems display Michaelis–Menten
behaviour.
ii) Compared to the protein-free catalyst (Table 3,
entry 1) all artificial metalloenzymes display higher
affinity for the substrate (i.e., smaller KM, Table 3, en-
tries 2–4).
iii) Compared to the protein-free catalyst (Table 3,
entry 1), all artificial metalloenzymes display higher
pseudo-first-order reaction rates (Table 3, entries 2–
4).
iv) Both avidin and streptavidin host proteins dis-
play similar kinetic behaviour (Table 3, entries 3 and
4).
v) The presence of large quantities of DMSO con-
tributes to significantly increase the reaction rates
(Table 3, entries 3 and 4).
It thus appears that both the affinity of the catalyst
for the substrate and the turnover rates are increased
with respect to the protein-free reference system [Rh-
ACHTUNGTRENNUNG(COD)Biot-1]+. A possible reason may be the pres-
ence of a hydrophobic cavity provided by the protein,
which contributes to increase the local concentration
of both the substrate and of the dihydrogen close to
the catalytic moiety. Accumulation within the host
protein of both substrate and dihydrogen are reflected
in lower KM and higher kcat, provided that the H2 oxi-
dative addition is the rate-determining step.[38]
Conclusions
This study, based on the incorporation of enantiopure
amino acid spacers between the biotin anchor and the
diphosphine moiety, considerably extends the poten-
tial of artificial hydrogenases based on the biotin
avidin technology. The most noteworthy features re-
vealed herein include:
i) Both avidin and streptavidin can be used as host
proteins to afford selective hybrid catalysts. For the
first time, egg-white avidin – which is considerably
cheaper than streptavidin – affords reduction products
with ee >86% in favour of the (S)-enantiomer using
[Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+  WTAvi. The chemoge-
netic optimization with streptavidin mutants, affords
hybrid catalysts for both (R)- and (S)-reduction prod-
ucts with ees >90%: for example, [Rh ACHTUNGTRENNUNG(COD)Biot-1]+
 WT Sav and [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+  S112W
Sav.
ii) In general, the nature of the spacer by-and-large
determines which enantiomer is preferentially pro-
duced. However, hybrid catalysts derived from Biot-
(S)-Phe-1, afford both (R)- and (S)-reduction prod-
ucts with ee >75%, depending on the nature of the
point mutation at position S112.
iii) Increased organic solvent tolerance: the use of
large amounts of DMSO (up to 45%) may allow one to
solubilize hydrophobic substrates, while EtOAc allows a
straightforward work-up to recover the substrate.
iii) Immobilization using Biotin-Sepharose with
little erosion of the selectivity: again here, the work-
up is considerably facilitated.
iv) Michaelis–Menten behaviour with increased
rate compared to the biotinylated catalyst devoid of
(strept)avidin.
Current efforts in this area are centred on the re-
duction of challenging dehydroamino acid substrates
(with limited aqueous solubility) as well as increasing
Figure 1. Saturation kinetics plots for the reduction of N-
acetamidoacrylic acid with [Rh ACHTUNGTRENNUNG(COD)Biot-1]+ (9% DMSO,
measured: squares), [Rh ACHTUNGTRENNUNG(COD)Biot-1]+  WT Sav (9%
DMSO, measured: triangles), [Rh ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+ 
WT Sav (30% DMSO, measured: circles) and [Rh-
ACHTUNGTRENNUNG(COD)Biot-(R)-Pro-1]+ WTAvi (30% DMSO, measured:
diamonds). All the fitted graphics are shown in solid lines.
Table 3.Michaelis–Menten parameters for the reduction of
N-acetamidoacrylic acid with selected artificial hydrogenas-
es at 2 bars H2 and room temperature.
Entry Ligand Protein Vmax
[mMmin1]
kcat
(min1)
KM
[mM]
1 Biot-1 - 0.173 3.06 7.38
2 Biot-1 WT
Sav
0.254 4.49 3.18
3 Biot-(R)-
Pro-1
WT
Sav
0.695 12.30 4.36
4 Biot-(R)-
Pro-1
WT
Avi
0.634 11.23 4.80
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the turnover numbers and turnover frequency of arti-
ficial hydrogenases based on the biotin-avidin tech-
nology.
Experimental Section
Ligand Synthesis and Characterization
All ligands used herein were reported (synthesis and full
characterization) in the supporting information of the pre-
liminary communication.[26]
Production and Purification of Streptavidin
The expression of mutant proteins Sav S112X has been de-
scribed elsewhere.[34] WT Avi was provided by Belovo.
Hydrogenation Reactions
General Aspects: All aqueous and organic solvents were
flushed with nitrogen during at least three hours. All manip-
ulations were performed in a glove-box under a nitrogen at-
mosphere. The metal source [Rh ACHTUNGTRENNUNG(COD)2]BF4 was dissolved
in DMSO (Acros) (4 mg, 16 mL DMSO), 1.56 mmol of this
solution were added to the appropriate aliquoted ligand
(2.02 mmol, 1.3 equivs. with respect to the metal source).
This solution was stirred for ca. 10 min.
Hydrogenation in Monophasic Media (9%, 27%, 45%
DMSO): A Pyrex tube (volume ca. 3 mL) was placed in an
autoclave and charged with an N-acetamidoacrylic acid solu-
tion in MES buffer 0.38M (130 mL of a 23.85 mM solution,
3.10 mmol), and an N-acetamidocinnamic acid solution in
MES buffer 0.38M (130 mL of a 23.85 mM solution, 3.10
mmol). The volume was adjusted with water (or with
DMSO, depending on the ratio of DMSO to be used) to 900
mL. The protein solution in water was then added (100 mL
of a 0.207 mM solution, 0.0207 mmol of the tetramer). The
precatalyst solution in DMSO (100 mL, 0.062 mmol) was
added last. The resulting mixture was vortexed, removed
from the glove-box and hydrogenated at 5 bars H2 for 15 h.
Hydrogenation in Biphasic Media (EtOAc): A Pyrex tube
(volume ca. 3 mL) was placed in an autoclave and charged
with an N-acetamidoacrylic acid solution in EtOAc (550 mL
of a 5.66 mM solution, 3.10 mmol), and an N-acetamidocin-
namic acid solution in EtOAc (550 mL of a 5.66 mM solu-
tion, 3.10 mmol). The buffer solution (580 mL of a 0.38M so-
lution) was added and the volume of the aqueous phase ad-
justed with water to 900 mL. The protein solution in water
was then added (100 mL of a 0.207 mM solution, 0.0207
mmol of the tetramer). The precatalyst solution in DMSO
(100 mL, 0.062 mmol) was added last. The resulting mixture
was vortexed and hydrogenated at 5 bars H2 for 15 h using
orbital shaking (ca. 200 rpm).
Note : In the case of hydrogenation without protein, the
volume of the protein solution was replaced by H2O.
All experiments were performed using MES buffer only.
This change does not influence significantly the activity and
enantioselectivity of experiments using avidin as the host
protein.
Hydrogenation Procedure for Immobilized Artificial Met-
alloenzymes: The commercial suspension of D-biotin-se-
pharose CL-4B {[105 mL, which corresponds to 0.031 mmol
biotin, capable of immobilizing 0.031 mmol tetrameric
(strept)avidin], [Affiland, Belgium, suspension in TBS
buffer pH 7.4, NaN3 0.02% (w/v)]} was decanted and
washed with water to afford wet beads, which were resus-
pended in water (105 mL total volume). The protein solution
(0.062 mmol, 2 equivs. vs. biotin sepharose, 300 mL) was
added. After ca. 10 min incubation, the immobilized protein
(containing 0.031 mmol of protein, corresponding to 0.093
mmol, free active sites) was washed at least three times with
H2O to remove the unbound protein and flushed with nitro-
gen for three hours. The precatalyst solution in DMSO (100
mL, 0.062 mmol, 0.66 equivs. with respect to the free biotin-
binding sites) was added last and was incubated with the im-
mobilized protein for 10 min. The immobilized catalyst was
subjected to several cycles of washing and decanting. The
catalytic runs were performed according to the standard or-
bital shaking procedure.
Hydrogenation Procedure for the Determination of Mi-
chaelis–Menten Parameters: A 15-mL glass vessel was
charged with a quantity (depending on the number of equiv-
alent of substrates used) a-acetamidoacrylic acid in MES
buffer (0.1M, pH 5.5). The volume was adjusted with water
to 9 mL followed by addition of (strept)avidin in H2O
(1 mL, 0.207 mM solution, 0.207 mmol of tetramer). The cat-
alyst precursor [Rh ACHTUNGTRENNUNG(COD)ACHTUNGTRENNUNG(spacer)]+ in DMSO (1 mL, 0.62
mmol) was added last. The resulting mixture was stirred for
ca. 2 mins to ensure a homogeneous medium. The reactor
was closed and was removed from the glove box and pres-
surized to 2 bars H2 and stirred mechanically at room tem-
perature. Aliquots (ca. 0.5 mL) were sampled at given times.
The initial conversions were collected for each concentra-
tion of substrate. The initial rate of the reaction (n) can be
calculated by:
This value gives the observed initial rate. The calculated
initial rate can be obtained by employing the following
equation:
The initial guessed values of both unknowns (KM and
Vmax) were introduced in the calculation. Then, a least
squares-minimization was performed to obtain the calculat-
ed initial rate n of the reaction and the Michaelis–Menten
parameters.
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Supporting Information
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